D
Agios Pharmaceuticals, Inc. AGIO
$27.71 -$0.73-2.57%
Recommendation
Sell
Prev Close
$28.44
Volume
634,779
Avg Vol (90D)
803,876
Market Cap
$1.63B
Dividend & Yield
--
52-Week Range
$26.66 - $62.58
P/E (TTM)
2.50
EPS (TTM)
$11.39
My Lists My Alerts
Rating
Reward
C-
Fair
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Fair
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Agios Pharmaceuticals (NASDAQ:AGIO) Trading Down 4.4% - What's Next?
4/3/2025 - MarketBeat
Pictet Asset Management Holding SA Lowers Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
4/3/2025 - Ticker Report
New Strong Sell Stocks for April 3rd
4/3/2025 - Zacks Investment Research
Prudential Financial Inc. Raises Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
4/2/2025 - Ticker Report
Artisan Partners Limited Partnership Purchases 107,292 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
3/30/2025 - MarketBeat
Wave Life Sciences (WVE) Stock Jumps 6.1%: Will It Continue to Soar?
3/27/2025 - Zacks Investment Research
Is Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) the Best Small Cap Stock to Buy Before They Explode?
3/27/2025 - Insider Monkey
Agios Pharmaceuticals (NASDAQ:AGIO) Shares Down 4.9% - Here's What Happened
3/26/2025 - MarketBeat
10 Best Small-Cap Stocks to Buy Before They Explode
3/26/2025 - Insider Monkey
Agios Pharmaceuticals (AGIO, $30.76) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 25, 2025
3/26/2025 - Tickeron - Stocks
Agios Pharmaceuticals (AGIO, $32.31) entered Uptrend as Momentum indicator ascends above 0 level on Mar 24, 2025
3/25/2025 - Tickeron - Stocks
Agios Pharmaceuticals (AGIO, $32.31) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 24, 2025
3/25/2025 - Tickeron - Stocks
First Week of November 21st Options Trading For Agios Pharmaceuticals (AGIO)
3/24/2025 - Stock Options Channel
Analysts See 69% Upside For The Holdings of XBI
3/21/2025 - ETF Channel
Connor Clark & Lunn Investment Management Ltd. Boosts Stock Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
3/17/2025 - MarketBeat
Bank of New York Mellon Corp Purchases 87,089 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
3/15/2025 - MarketBeat
Erste Asset Management GmbH Has $66.43 Million Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
3/13/2025 - MarketBeat
Q1 EPS Estimate for Agios Pharmaceuticals Lowered by Analyst
3/10/2025 - MarketBeat
Agios Pharmaceuticals (AGIO, $32.38) price exceeded its 50-day Moving Average on March 07, 2025
3/8/2025 - Tickeron - Stocks
Agios Pharmaceuticals (AGIO, $32.38) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 7, 2025
3/8/2025 - Tickeron - Stocks
Agios Pharmaceuticals (AGIO, $33.98) price moved above its 50-day Moving Average on March 06, 2025
3/7/2025 - Tickeron - Technical Analysis
Agios Pharmaceuticals (AGIO, $33.98) entered Uptrend as Momentum indicator ascends above 0 level on Mar 06, 2025
3/7/2025 - Tickeron - Technical Analysis
Agios Pharmaceuticals (AGIO, $33.98) entered Uptrend as Momentum indicator ascends above 0 level on Mar 06, 2025
3/7/2025 - Tickeron - Stocks
Agios Pharmaceuticals (AGIO, $33.98) price moved above its 50-day Moving Average on March 06, 2025
3/7/2025 - Tickeron - Stocks
Agios Pharmaceuticals (AGIO, $33.95) price moved above its 50-day Moving Average on March 05, 2025
3/6/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$36.50M
EBITDA (TTM)
-$420.08M
EBIT (TTM)
-$425.74M
Net Income (TTM)
$673.73M
Balance Sheet
Total Assets (Q)
$1.66B
Total Debt (Q)
$56.99M
Total Liabilities (Q)
$122.24M
Book Value Per Share (Q)
$26.96
Cash Flow
Cash from Operations (TTM)
-$389.84M
Cash from Investing (TTM)
$363.44M
Cash from Financing (TTM)
$14.44M
Net Change in Cash (TTM)
-$11.96M
Filings
Filing Date
Thursday, February 13, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Loading...
Beta
1.72
7-Day Total Return
-9.92%
30-Day Total Return
-17.90%
60-Day Total Return
-17.38%
90-Day Total Return
-49.27%
Year to Date Total Return
-12.97%
1-Year Total Return
-2.67%
2-Year Total Return
22.07%
3-Year Total Return
-11.81%
5-Year Total Return
-26.09%
52-week Low
Apr 01, 2025 - $26.66
52-week High
Nov 11, 2024 - $62.58
Valuation
Market Cap
$1.63B - Small Cap
Enterprise Value
$154.46M
Price/Sales (TTM)
44.50
Price/Book (Q)
1.05
Dividends and Shares
Shares Outstanding
57.10M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.agios.com
Phone Number
617 649 8600
Address
88 Sidney Street
Cambridge, MA 02139
Country
United States
Year Founded
2007
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND... more
NASDAQ 04/03/2025 4:00PM Eastern Quotes delayed
Weiss Ratings